Pioneering stem cell treatment could be used for the first time on stroke patients in trials at a Scottish hospital.
Doctors at Glasgow’s Southern General Hospital are set to launch tests using cells grown from a single aborted human foetus.
It follows years of work by an English research firm. ReNeuron spent £10million of private investors’ money developing what they hope will help improve the quality of life for thousands of stroke victims.
They hope it will put the UK at the forefront of developing stem cell therapy for incurable disease.
The research has been approved by the UK regulator but has still to pass an ethics committee, the company said.
The Catholic Church said they support stem cell research in principle from “ethical sources”.
But a spokesman for the Church said: “If they’re from an aborted foetus, then that is immoral and unethical.”
• Full story at the Daily Record.